SRC
Shufro Rose & Co’s Teva Pharmaceuticals TEVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-16,779
| Closed | -$361K | – | 307 |
|
|
2018
Q3 | $361K | Sell |
16,779
-100
| -0.6% | -$2.15K | 0.03% | 208 |
|
|
2018
Q2 | $410K | Sell |
16,879
-800
| -5% | -$19.4K | 0.04% | 185 |
|
|
2018
Q1 | $302K | Sell |
17,679
-40
| -0.2% | -$683 | 0.03% | 226 |
|
|
2017
Q4 | $336K | Sell |
17,719
-8,225
| -32% | -$156K | 0.03% | 209 |
|
|
2017
Q3 | $457K | Sell |
25,944
-29,157
| -53% | -$514K | 0.05% | 172 |
|
|
2017
Q2 | $1.83M | Buy |
55,101
+4,780
| +9% | +$159K | 0.2% | 84 |
|
|
2017
Q1 | $1.62M | Sell |
50,321
-2,020
| -4% | -$64.8K | 0.17% | 89 |
|
|
2016
Q4 | $1.9M | Sell |
52,341
-3,494
| -6% | -$127K | 0.21% | 82 |
|
|
2016
Q3 | $2.57M | Sell |
55,835
-5,342
| -9% | -$246K | 0.29% | 73 |
|
|
2016
Q2 | $3.07M | Sell |
61,177
-688
| -1% | -$34.6K | 0.34% | 70 |
|
|
2016
Q1 | $3.31M | Buy |
61,865
+2,070
| +3% | +$111K | 0.37% | 67 |
|
|
2015
Q4 | $3.92M | Sell |
59,795
-100
| -0.2% | -$6.56K | 0.45% | 62 |
|
|
2015
Q3 | $3.38M | Sell |
59,895
-3,995
| -6% | -$226K | 0.41% | 63 |
|
|
2015
Q2 | $3.78M | Sell |
63,890
-2,670
| -4% | -$158K | 0.4% | 66 |
|
|
2015
Q1 | $4.15M | Sell |
66,560
-2,365
| -3% | -$147K | 0.43% | 67 |
|
|
2014
Q4 | $3.96M | Sell |
68,925
-2,930
| -4% | -$168K | 0.4% | 68 |
|
|
2014
Q3 | $3.86M | Sell |
71,855
-2,912
| -4% | -$157K | 0.4% | 68 |
|
|
2014
Q2 | $3.92M | Sell |
74,767
-5,726
| -7% | -$300K | 0.4% | 65 |
|
|
2014
Q1 | $4.25M | Sell |
80,493
-760
| -0.9% | -$40.2K | 0.45% | 63 |
|
|
2013
Q4 | $3.26M | Sell |
81,253
-409,841
| -83% | -$16.4M | 0.34% | 69 |
|
|
2013
Q3 | $18.6M | Buy |
491,094
+11,320
| +2% | +$428K | 2.11% | 13 |
|
|
2013
Q2 | $18.8M | Buy |
+479,774
| New | +$18.8M | 2.23% | 11 |
|